UKRI-NIHR Collaboration Response to Recommendation
TOTAL SCORE: 10
Score
A1 (Feasibility increased by continuance of pandemic): +1
A2 (Necessity increased by covid pandemic): +1
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): +1
C1 (Market readiness applicability): 0
C2 (Project readiness): 0
C3 (Move to market readiness): 0
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness):+2
F (Dividends - does the recommendation aid in social activity and inclusivity?): 0
This scores strong on and cross-sector coordination (D3) and very strong on disruption (E). Accelerated clinical translation of biomedicine has the potential to profoundly alter the entire nature of the challenge. However, rapid translation will require the judicious use of biomarkers if it is to meet the needs of the 2035 goal (B1).
RECOMMENDATION SUMMARY
“We recommend that UK Research and Innovation and the National Institute for Health Research commit to working more closely to ensure rapid translation of ageing research into clinical benefit. (Paragraph 180)”
Score
A1 (Feasibility increased by continuance of pandemic): +1
A2 (Necessity increased by covid pandemic): +1
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): +1
C1 (Market readiness applicability): 0
C2 (Project readiness): 0
C3 (Move to market readiness): 0
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness):+2
F (Dividends - does the recommendation aid in social activity and inclusivity?): 0
This scores strong on and cross-sector coordination (D3) and very strong on disruption (E). Accelerated clinical translation of biomedicine has the potential to profoundly alter the entire nature of the challenge. However, rapid translation will require the judicious use of biomarkers if it is to meet the needs of the 2035 goal (B1).
RECOMMENDATION SUMMARY
“We recommend that UK Research and Innovation and the National Institute for Health Research commit to working more closely to ensure rapid translation of ageing research into clinical benefit. (Paragraph 180)”